{
    "clinical_study": {
        "@rank": "130959", 
        "arm_group": [
            {
                "arm_group_label": "FloSeal group", 
                "arm_group_type": "Experimental", 
                "description": "After laparoscopic ovarian cystectomy, hemostasis will be performed using FloSeal (1 vial of FloSeal 5mL per unilateral ovarian cystectomy)"
            }, 
            {
                "arm_group_label": "Electrocautery group", 
                "arm_group_type": "Active Comparator", 
                "description": "After laparoscopic ovarian cystectomy, hemostasis will be performed using electrocautery"
            }
        ], 
        "brief_summary": {
            "textblock": "To compare the efficacy in postoperative hemostasis and in sparing postoperative ovarian\n      function between FloSeal and Electrocauterization in laparoscopic ovarian cystectomy"
        }, 
        "brief_title": "Efficacy Study of FloSeal in Hemostasis After Laparoscopic Ovarian Cystectomy", 
        "condition": "Benign Ovarian Tumor", 
        "condition_browse": {
            "mesh_term": "Ovarian Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Premenopausal women\n\n          -  Patients who is planned to undergo laparoscopic ovarian cystectomy\n\n          -  American Society of Anesthesiologists Physical Status classification (ASA PS) 1-2\n\n          -  Patients with adequate bone marrow, renal and hepatic function:\n\n        WBC > 3,000 cells/mcl Platelets >100,000/mcl Creatinine <2.0 mg/dL Bilirubin <1.5 x normal\n        and SGOT or SGPT <3 x normal\n\n          -  Patient must be suitable candidates for surgery\n\n          -  Patients who have signed an approved Informed Consent\n\n        Exclusion Criteria:\n\n          -  Patients with a history of pelvic or abdominal radiotherapy;\n\n          -  Patients who are pregnant or nursing\n\n          -  Patients who is receiving or requires hormone replacement therapy after surgery\n\n          -  Patients who is undergoing hysterectomy at this time\n\n          -  Patients who is undergoing unilateral or bilateral oophorectomy\n\n          -  Previous history of ovarian cystectomy or oophorectomy\n\n          -  Patients with contraindications to surgery\n\n          -  Unfit for Surgery: serious concomitant systemic disorders incompatible with the study\n             (at the discretion of the investigator)\n\n          -  Patient compliance and geographic proximity that do not allow adequate follow-up.\n\n          -  Hormone therapy within 3 months before surgery"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "September 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01683877", 
            "org_study_id": "FloSeal-OC"
        }, 
        "intervention": [
            {
                "arm_group_label": "FloSeal group", 
                "description": "After laparoscopic ovarian cystectomy, hemostasis will be performed using FloSeal (1 vial of FloSeal 5mL per unilateral ovarian cystectomy)", 
                "intervention_name": "FloSeal application", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Electrocautery group", 
                "description": "After laparoscopic ovarian cystectomy, hemostasis will be performed using electrocautery", 
                "intervention_name": "Electrocautery", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Hemostatics"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "September 16, 2012", 
        "location": {
            "contact": {
                "email": "jhnam@amc.seoul.kr", 
                "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
                "phone": "82-2-3010-3633"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "138-736"
                }, 
                "name": "Department of Obstetrics and Gynecology, University of Ulsan College of Medicine, Asan Medical Center"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "PROSPECTIVE RANDOMIZED CONPARISON OF ELECTRONIC DIATHERMY VERSUS FLOSEAL IN HEMOSTASIS AFTER LAPAROSCOPIC OVARIAN CYSTECTOMY", 
        "overall_contact": {
            "email": "jhnam@amc.seoul.kr", 
            "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
            "phone": "82-2-3010-3633"
        }, 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Joo-Hyun Nam, M.D., Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Asan Medical Center Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Hemostasis time", 
            "safety_issue": "No", 
            "time_frame": "Immediately after operation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01683877"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Joo-Hyun Nam", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Ovarian function after surgery", 
                "safety_issue": "No", 
                "time_frame": "within 6 months after surgery"
            }, 
            {
                "measure": "Operative time", 
                "safety_issue": "No", 
                "time_frame": "1 day (Immediately after surgery)"
            }, 
            {
                "measure": "Intraoperative blood loss", 
                "safety_issue": "No", 
                "time_frame": "During surgery"
            }, 
            {
                "measure": "Postoperative drainage volume", 
                "safety_issue": "No", 
                "time_frame": "within 2 days after surgery"
            }, 
            {
                "measure": "Postoperative drainage duration", 
                "safety_issue": "No", 
                "time_frame": "within 1 week after surgery"
            }, 
            {
                "measure": "Length of postoperative stay", 
                "safety_issue": "No", 
                "time_frame": "within 1 month after surgery"
            }, 
            {
                "description": "Postoperative complications will be evaluated with Dindo's classification for postoperative complication and CTCAE v4.0.", 
                "measure": "Postoperative complications", 
                "safety_issue": "Yes", 
                "time_frame": "within 1 months after surgery"
            }
        ], 
        "source": "Asan Medical Center", 
        "sponsors": {
            "collaborator": {
                "agency": "Baxter Healthcare Corporation", 
                "agency_class": "Industry"
            }, 
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "September 2012"
    }
}